Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers

Introduction: Mutations in the progranulin (GRN) gene are a major source of inherited frontotemporal degeneration (FTD) spectrum disorders associated with TDP-43 proteinopathy. We use structural MRI to identify regions of baseline differences and longitudinal changes in gray matter (GM) and white ma...

Full description

Bibliographic Details
Main Authors: Christopher A. Olm, Corey T. McMillan, David J. Irwin, Vivianna M. Van Deerlin, Philip A. Cook, James C. Gee, Murray Grossman
Format: Article
Language:English
Published: Elsevier 2018-01-01
Series:NeuroImage: Clinical
Online Access:http://www.sciencedirect.com/science/article/pii/S2213158218301633
_version_ 1819040109404618752
author Christopher A. Olm
Corey T. McMillan
David J. Irwin
Vivianna M. Van Deerlin
Philip A. Cook
James C. Gee
Murray Grossman
author_facet Christopher A. Olm
Corey T. McMillan
David J. Irwin
Vivianna M. Van Deerlin
Philip A. Cook
James C. Gee
Murray Grossman
author_sort Christopher A. Olm
collection DOAJ
description Introduction: Mutations in the progranulin (GRN) gene are a major source of inherited frontotemporal degeneration (FTD) spectrum disorders associated with TDP-43 proteinopathy. We use structural MRI to identify regions of baseline differences and longitudinal changes in gray matter (GM) and white matter (WM) in presymptomatic GRN mutation carriers (pGRN+) compared to young controls (yCTL). Methods: Cognitively intact first-degree relatives of symptomatic GRN+ FTD patients with identified GRN mutations (pGRN+; N = 11, mean age = 41.4) and matched yCTL (N = 11, mean age = 53.6) were identified. They completed a MRI session with T1-weighted imaging to assess GM density (GMD) and diffusion-weighted imaging (DWI) to assess fractional anisotropy (FA). Participants completed a follow-up session with T1 and DWI imaging (pGRN+ mean interval 2.20 years; yCTL mean interval 3.27 years). Annualized changes of GMD and FA were also compared. Results: Relative to yCTL, pGRN+ individuals displayed reduced GMD at baseline in bilateral orbitofrontal, insular, and anterior temporal cortices. pGRN+ also showed greater annualized GMD changes than yCTL at follow-up in right orbitofrontal and left occipital cortices. We also observed reduced FA at baseline in bilateral superior longitudinal fasciculus, left corticospinal tract, and frontal corpus callosum in pGRN+ relative to yCTL, and pGRN+ displayed greater annualized longitudinal FA change in right superior longitudinal fasciculus and frontal corpus callosum. Conclusions: Longitudinal MRI provides evidence of progressive GM and WM changes in pGRN+ participants relative to yCTL. Structural MRI illustrates the natural history of presymptomatic GRN carriers, and may provide an endpoint during disease-modifying treatment trials for pGRN+ individuals at risk for FTD. Keywords: Frontotemporal lobar degeneration, Magnetic resonance imaging, Neuroimaging, Progranulin, Presymptomatic, Longitudinal
first_indexed 2024-12-21T09:03:52Z
format Article
id doaj.art-5a4a8ca5b005414e819bbe1cb4ff445a
institution Directory Open Access Journal
issn 2213-1582
language English
last_indexed 2024-12-21T09:03:52Z
publishDate 2018-01-01
publisher Elsevier
record_format Article
series NeuroImage: Clinical
spelling doaj.art-5a4a8ca5b005414e819bbe1cb4ff445a2022-12-21T19:09:25ZengElsevierNeuroImage: Clinical2213-15822018-01-0119497506Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriersChristopher A. Olm0Corey T. McMillan1David J. Irwin2Vivianna M. Van Deerlin3Philip A. Cook4James C. Gee5Murray Grossman6Penn Frontotemporal Degeneration Center, Department of Neurology, University of Pennsylvania, Philadelphia, PA, United States; Penn Image Computing and Science Laboratory, Department of Radiology, University of Pennsylvania, Philadelphia, PA, United StatesPenn Frontotemporal Degeneration Center, Department of Neurology, University of Pennsylvania, Philadelphia, PA, United StatesPenn Frontotemporal Degeneration Center, Department of Neurology, University of Pennsylvania, Philadelphia, PA, United States; Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, United StatesCenter for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, United StatesPenn Image Computing and Science Laboratory, Department of Radiology, University of Pennsylvania, Philadelphia, PA, United StatesPenn Image Computing and Science Laboratory, Department of Radiology, University of Pennsylvania, Philadelphia, PA, United StatesPenn Frontotemporal Degeneration Center, Department of Neurology, University of Pennsylvania, Philadelphia, PA, United States; Corresponding author at: Hospital of the University of Pennsylvania, 3400 Spruce Street, 3 West Gates, Philadelphia, PA 19104, United StatesIntroduction: Mutations in the progranulin (GRN) gene are a major source of inherited frontotemporal degeneration (FTD) spectrum disorders associated with TDP-43 proteinopathy. We use structural MRI to identify regions of baseline differences and longitudinal changes in gray matter (GM) and white matter (WM) in presymptomatic GRN mutation carriers (pGRN+) compared to young controls (yCTL). Methods: Cognitively intact first-degree relatives of symptomatic GRN+ FTD patients with identified GRN mutations (pGRN+; N = 11, mean age = 41.4) and matched yCTL (N = 11, mean age = 53.6) were identified. They completed a MRI session with T1-weighted imaging to assess GM density (GMD) and diffusion-weighted imaging (DWI) to assess fractional anisotropy (FA). Participants completed a follow-up session with T1 and DWI imaging (pGRN+ mean interval 2.20 years; yCTL mean interval 3.27 years). Annualized changes of GMD and FA were also compared. Results: Relative to yCTL, pGRN+ individuals displayed reduced GMD at baseline in bilateral orbitofrontal, insular, and anterior temporal cortices. pGRN+ also showed greater annualized GMD changes than yCTL at follow-up in right orbitofrontal and left occipital cortices. We also observed reduced FA at baseline in bilateral superior longitudinal fasciculus, left corticospinal tract, and frontal corpus callosum in pGRN+ relative to yCTL, and pGRN+ displayed greater annualized longitudinal FA change in right superior longitudinal fasciculus and frontal corpus callosum. Conclusions: Longitudinal MRI provides evidence of progressive GM and WM changes in pGRN+ participants relative to yCTL. Structural MRI illustrates the natural history of presymptomatic GRN carriers, and may provide an endpoint during disease-modifying treatment trials for pGRN+ individuals at risk for FTD. Keywords: Frontotemporal lobar degeneration, Magnetic resonance imaging, Neuroimaging, Progranulin, Presymptomatic, Longitudinalhttp://www.sciencedirect.com/science/article/pii/S2213158218301633
spellingShingle Christopher A. Olm
Corey T. McMillan
David J. Irwin
Vivianna M. Van Deerlin
Philip A. Cook
James C. Gee
Murray Grossman
Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers
NeuroImage: Clinical
title Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers
title_full Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers
title_fullStr Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers
title_full_unstemmed Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers
title_short Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers
title_sort longitudinal structural gray matter and white matter mri changes in presymptomatic progranulin mutation carriers
url http://www.sciencedirect.com/science/article/pii/S2213158218301633
work_keys_str_mv AT christopheraolm longitudinalstructuralgraymatterandwhitemattermrichangesinpresymptomaticprogranulinmutationcarriers
AT coreytmcmillan longitudinalstructuralgraymatterandwhitemattermrichangesinpresymptomaticprogranulinmutationcarriers
AT davidjirwin longitudinalstructuralgraymatterandwhitemattermrichangesinpresymptomaticprogranulinmutationcarriers
AT viviannamvandeerlin longitudinalstructuralgraymatterandwhitemattermrichangesinpresymptomaticprogranulinmutationcarriers
AT philipacook longitudinalstructuralgraymatterandwhitemattermrichangesinpresymptomaticprogranulinmutationcarriers
AT jamescgee longitudinalstructuralgraymatterandwhitemattermrichangesinpresymptomaticprogranulinmutationcarriers
AT murraygrossman longitudinalstructuralgraymatterandwhitemattermrichangesinpresymptomaticprogranulinmutationcarriers